361 related articles for article (PubMed ID: 38473281)
1. Unfolding the Complexity of Exosome-Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma.
Chak PT; Kam NW; Choi TH; Dai W; Kwong DL
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473281
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma.
Shan Y; Zhou P; Zhou Q; Yang L
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565418
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.
Lee PJ; Sui YH; Liu TT; Tsang NM; Huang CH; Lin TY; Chang KP; Liu SC
J Exp Clin Cancer Res; 2022 Aug; 41(1):254. PubMed ID: 35986369
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.
Su ZY; Siak PY; Leong CO; Cheah SC
Front Oncol; 2022; 12():840467. PubMed ID: 35311066
[TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.
Wang X; Zhang Y; Mu X; Tu CR; Chung Y; Tsao SW; Chan GC; Leung WH; Lau YL; Liu Y; Tu W
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35105688
[TBL] [Abstract][Full Text] [Related]
6. The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application.
Luo H; Yi B
Int J Biol Sci; 2021; 17(9):2147-2156. PubMed ID: 34239345
[TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.
Liu H; Tang L; Li Y; Xie W; Zhang L; Tang H; Xiao T; Yang H; Gu W; Wang H; Chen P
Mol Cancer; 2024 Jan; 23(1):20. PubMed ID: 38254110
[TBL] [Abstract][Full Text] [Related]
8. Exosomes in nasopharyngeal carcinoma.
Liu Y; Wen J; Huang W
Clin Chim Acta; 2021 Dec; 523():355-364. PubMed ID: 34666030
[TBL] [Abstract][Full Text] [Related]
9. Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis.
Zhang K; Liu D; Zhao J; Shi S; He X; Da P; You Y; You B
Cell Death Dis; 2021 May; 12(6):554. PubMed ID: 34050127
[TBL] [Abstract][Full Text] [Related]
10. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.
Wu A; Luo N; Xu Y; Du N; Li L; Liu Q
Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330
[TBL] [Abstract][Full Text] [Related]
11. EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K/AKT pathway-suppressed ROS.
Li F; Zhao X; Sun R; Ou J; Huang J; Yang N; Xu T; Li J; He X; Li C; Yang M; Zhang Q
J Extracell Vesicles; 2020 Oct; 10(1):e12003. PubMed ID: 33304472
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma.
Liao C; Liu H; Luo X
Am J Cancer Res; 2021; 11(6):2508-2520. PubMed ID: 34249413
[TBL] [Abstract][Full Text] [Related]
13. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
14. Exosomes in Nasopharyngeal Carcinoma.
Zhou Y; Xia L; Lin J; Wang H; Oyang L; Tan S; Tian Y; Su M; Wang H; Cao D; Liao Q
J Cancer; 2018; 9(5):767-777. PubMed ID: 29581754
[TBL] [Abstract][Full Text] [Related]
15. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
Yip WK; Abdullah MA; Yusoff SM; Seow HF
Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H
Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623
[TBL] [Abstract][Full Text] [Related]
17. Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
Dochi H; Kondo S; Komura S; Moriyama-Kita M; Komori T; Nanbo A; Sakaguchi M; Fukuyo M; Hamabe-Horiike T; Tanaka M; Mizokami H; Kano M; Kitagawa Y; Kobayashi E; Hirai N; Ueno T; Nakanishi Y; Endo K; Sugimoto H; Hanayama R; Kaneda A; Yoshizaki T
Int J Cancer; 2024 Mar; 154(5):895-911. PubMed ID: 37907830
[TBL] [Abstract][Full Text] [Related]
18. [Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis].
Chen X; Li D; Huang Z; Zhong S; Cai L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1776-1783. PubMed ID: 33380393
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review).
Huang H; Yao Y; Deng X; Huang Z; Chen Y; Wang Z; Hong H; Huang H; Lin T
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37417358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
